Literature DB >> 9713444

Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis.

Y Takemoto1, M Sakatani, S Takami, T Tachibana, J Higaki, T Ogihara, T Miki, T Katsuya, T Tsuchiyama, A Yoshida, H Yu, Y Tanio, E Ueda.   

Abstract

BACKGROUND: Serum angiotensin converting enzyme (SACE) is considered to reflect disease activity in sarcoidosis. SACE activity is increased in many patients with active sarcoid lesions. The mechanism for the increased SACE activity in this disease has not been clarified. ACE insertion/deletion (I/D) gene polymorphism has been reported to have an association with SACE levels in sarcoidosis, but no evidence of an association between angiotensin II receptor gene polymorphism and SACE in this disease has been found. A study of the association of angiotensin II receptor gene polymorphisms with sarcoidosis was therefore undertaken.
METHODS: ACE (I/D), angiotensin II type 1 receptor (AGTR1), and angiotensin II type 2 receptor (AGTR2) gene polymorphisms were investigated by polymerase chain reaction (PCR) and SACE levels were measured in three groups of patients: those with sarcoidosis or tuberculosis and normal controls.
RESULTS: There was no difference in allele frequency of AGTR1 and AGTR2 polymorphism among the three groups. Neither AGTR1 nor AGTR2 polymorphisms were associated with sarcoidosis. SACE activity was higher in patients with sarcoidosis with the AGTR1 A/C genotype than in others. However, this tendency was not detected in patients with tuberculosis.
CONCLUSIONS: The AGTR1 allele C is associated with high activity of SACE in patients with sarcoidosis. It is another predisposing factor for high levels of SACE in patients with sarcoidosis and is considered to be an independent factor from the ACE D allele for high levels of SACE in sarcoidosis. This fact could be one of the explanations for the increased SACE activity in sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9713444      PMCID: PMC1745244          DOI: 10.1136/thx.53.6.459

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  14 in total

1.  Serum angiotensin-converting enzyme for diagnosis and therapeutic evaluation of sarcoidosis.

Authors:  J Lieberman; A Nosal; A Schlessner; A Sastre-Foken
Journal:  Am Rev Respir Dis       Date:  1979-08

2.  Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor.

Authors:  R Takayanagi; K Ohnaka; Y Sakai; R Nakao; T Yanase; M Haji; T Inagami; H Furuta; D F Gou; M Nakamuta
Journal:  Biochem Biophys Res Commun       Date:  1992-03-16       Impact factor: 3.575

3.  Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis.

Authors:  J Lieberman
Journal:  Am J Med       Date:  1975-09       Impact factor: 4.965

4.  Serum angiotensin-converting enzyme activity as an indicator of prognosis in sarcoidosis.

Authors:  E Ueda; T Kawabe; T Tachibana; T Kokubu
Journal:  Am Rev Respir Dis       Date:  1980-04

5.  Genomic organization and polymorphism of human angiotensin II type 2 receptor: no evidence for its gene mutation in two families of human premature ovarian failure syndrome.

Authors:  T Katsuya; M Horiuchi; S Minami; G Koike; N F Santoro; A J Hsueh; V J Dzau
Journal:  Mol Cell Endocrinol       Date:  1997-03-28       Impact factor: 4.102

6.  Genetic polymorphisms of the angiotensin II type 1 (AT1) receptor gene.

Authors:  A Rolfs; I Weber-Rolfs; V Regitz-Zagrosek; H Kallisch; K Riedel; E Fleck
Journal:  Eur Heart J       Date:  1994-12       Impact factor: 29.983

7.  Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction.

Authors:  L Tiret; A Bonnardeaux; O Poirier; S Ricard; P Marques-Vidal; A Evans; D Arveiler; G Luc; F Kee; P Ducimetière
Journal:  Lancet       Date:  1994-10-01       Impact factor: 79.321

8.  Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension.

Authors:  A Bonnardeaux; E Davies; X Jeunemaitre; I Féry; A Charru; E Clauser; L Tiret; F Cambien; P Corvol; F Soubrier
Journal:  Hypertension       Date:  1994-07       Impact factor: 10.190

9.  Elevated serum angiotensin I converting enzyme in sarcoidosis.

Authors:  B L Fanburg; M D Schoenberger; B Bachus; G L Snider
Journal:  Am Rev Respir Dis       Date:  1976-09

10.  Colorimetry of angiotensin-I converting enzyme activity in serum.

Authors:  Y Kasahara; Y Ashihara
Journal:  Clin Chem       Date:  1981-11       Impact factor: 8.327

View more
  6 in total

1.  Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis.

Authors:  Igor Medica; Andrej Kastrin; Ales Maver; Borut Peterlin
Journal:  J Hum Genet       Date:  2007-09-04       Impact factor: 3.172

Review 2.  Sarcoidosis 2001.

Authors:  D G James
Journal:  Postgrad Med J       Date:  2001-03       Impact factor: 2.401

Review 3.  Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review.

Authors:  Amy K Mottl; David A Shoham; Kari E North
Journal:  Genet Med       Date:  2008-08       Impact factor: 8.822

4.  Leptin, Galectin-3 and Angiotensin II Type 1 Receptor Polymorphism in Overweight and Obese Patients with Heart Failure - Role and Functional Interplay.

Authors:  Alexandra Dadarlat-Pop; Dana Pop; Lucia Procopciuc; Adela Sitar-Taut; Dumitru Zdrenghea; Gyorgy Bodizs; Raluca Tomoaia; Diana Gurzau; Florina Fringu; Silvana Susca-Hojda; Anca D Buzoianu
Journal:  Int J Gen Med       Date:  2021-05-06

Review 5.  Surfactant gene polymorphisms and interstitial lung diseases.

Authors:  Panagiotis Pantelidis; Srihari Veeraraghavan; Roland M du Bois
Journal:  Respir Res       Date:  2001-11-29

6.  A pilot study of angiotensin converting enzyme (ACE) genotype and return of spontaneous circulation following out-of-hospital cardiac arrest.

Authors:  Thomas W Lindner; Charles D Deakin; Hildegunn Aarsetøy; Sten Rubertsson; Jon-Kenneth Heltne; Eldar Søreide
Journal:  Open Heart       Date:  2014-08-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.